Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Shinji, Kamei"'
Autor:
Satoshi Yamaguchi, Koki Mise, Jun Wada, Kenichi Shikata, Takashi Matsuoka, Haruhito A Uchida, Asami Ueno, Yasuhiro Onishi, Ayaka Kanno, Ichiro Nojima, Chigusa Higuchi, Satoshi Miyamoto, Atsuko Nakatsuka, Jun Eguchi, Kazuyuki Hida, Akihiro Katayama, Mayu Watanabe, Tatsuaki Nakato, Atsuhito Tone, Sanae Teshigawara, Shinji Kamei, Kazutoshi Murakami, Ikki Shimizu, Katsuhito Miyashita, Shinichiro Ando, Tomokazu Nunoue
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 12, Iss 3 (2024)
Introduction ACE cleaves angiotensin I (Ang I) to angiotensin II (Ang II) inducing vasoconstriction via Ang II type 1 (AT1) receptor, while ACE2 cleaves Ang II to Ang (1–7) causing vasodilatation by acting on the Mas receptor. In diabetic kidney di
Externí odkaz:
https://doaj.org/article/c9419a733e74406e84a4c4daa6de173f
Autor:
Yoshiro Fushimi, Fuminori Tatsumi, Junpei Sanada, Masashi Shimoda, Shinji Kamei, Shuhei Nakanishi, Kohei Kaku, Tomoatsu Mune, Hideaki Kaneto
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-6 (2021)
Abstract Background Various adrenal disorders including primary aldosteronism and Cushing’s syndrome lead to the cause of hypertension. Although primary aldosteronism is sometimes complicated with preclinical Cushing’s syndrome, concurrence of ov
Externí odkaz:
https://doaj.org/article/a4a02b5b9dfd47c2845745ab2f457c8a
Autor:
Yoshiro Fushimi, Shinji Kamei, Fuminori Tatsumi, Junpei Sanada, Masashi Shimoda, Tomohiko Kimura, Atsushi Obata, Shuhei Nakanishi, Kohei Kaku, Tomoatsu Mune, Hideaki Kaneto
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-5 (2021)
Abstract Background Multiple endocrine neoplasia type 1 (MEN1) is a syndrome characterized by pituitary neoplasia, primary hyperparathyroidism and pancreatic endocrine tumor. Here we show a case of MEN1 with a germline frameshift mutation in its gene
Externí odkaz:
https://doaj.org/article/8c88e3dc93f8443f96a16f8ac303e2ba
Autor:
Hideaki Kaneto, Shinji Kamei, Fuminori Tatsumi, Masashi Shimoda, Tomohiko Kimura, Shuhei Nakanishi, Yoshiyuki Miyaji, Atsushi Nagai, Kohei Kaku, Tomoatsu Mune
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
IntroductionPheochromocytoma is a catecholamine-producing tumor in the adrenal medulla and is often accompanied by hypertension, hyperglycemia, hypermetabolism, headache, and hyperhidrosis, and it is classified as benign and malignant pheochromocytom
Externí odkaz:
https://doaj.org/article/b5220819f5a042e180e18d05ac896b48
Autor:
Koki Mise, Mariko Imamura, Satoshi Yamaguchi, Mayu Watanabe, Chigusa Higuchi, Akihiro Katayama, Satoshi Miyamoto, Haruhito A. Uchida, Atsuko Nakatsuka, Jun Eguchi, Kazuyuki Hida, Tatsuaki Nakato, Atsuhito Tone, Sanae Teshigawara, Takashi Matsuoka, Shinji Kamei, Kazutoshi Murakami, Ikki Shimizu, Katsuhiro Miyashita, Shinichiro Ando, Tomokazu Nunoue, Michihiro Yoshida, Masao Yamada, Kenichi Shikata, Jun Wada
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Background: Although various biomarkers predict cardiovascular event (CVE) in patients with diabetes, the relationship of urinary glycan profile with CVE in patients with diabetes remains unclear.Methods: Among 680 patients with type 2 diabetes, we e
Externí odkaz:
https://doaj.org/article/1bfeece3c1bd4e7f9cdd4a08de653547
Autor:
Junpei Sanada, Fuminori Tatsumi, Shinji Kamei, Yoshiro Fushimi, Masashi Shimoda, Kenji Kohara, Shuhei Nakanishi, Kohei Kaku, Tomoatsu Mune, Hideaki Kaneto
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
BackgroundPituitary adenoma producing growth hormone (GH) or thyroid-stimulating hormone (TSH) is characterized by various specific symptoms and/or findings. However, the frequency of pituitary adenoma producing both hormones is relatively low. In th
Externí odkaz:
https://doaj.org/article/26a70c8ff59445c58cef7f30c6233498
Autor:
Hidenori Hirukawa, Shinji Kamei, Tomohiko Kimura, Atsushi Obata, Kenji Kohara, Fuminori Tatsumi, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Publikováno v:
Journal of Diabetes Research, Vol 2018 (2018)
It is very important to explore how we can reduce urinary albumin excretion which is an independent risk factor for ischemic heart disease. In this study, we retrospectively evaluated the effects of RAS inhibitor therapy on diabetic nephropathy in Ja
Externí odkaz:
https://doaj.org/article/991aba87ebeb4e1f8ccde23f87a90c59
Autor:
Shinji Kamei, Masahiro Iwamoto, Miyuki Kameyama, Masashi Shimoda, Tomoe Kinoshita, Atsushi Obata, Tomohiko Kimura, Hidenori Hirukawa, Fuminori Tatsumi, Kenji Kohara, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Publikováno v:
Journal of Diabetes Research, Vol 2018 (2018)
Sodium-glucose cotransporter 2 inhibitor tofogliflozin is a new type of antidiabetic drug for individuals with type 2 diabetes mellitus (T2DM). The aim of this study was to examine in which type of individuals and/or under which conditions tofogliflo
Externí odkaz:
https://doaj.org/article/4b824446fa7342d8955a5bc5384c7041
Autor:
Shuhei Nakanishi, Shinji Kamei, Tomoatsu Mune, Fuminori Tatsumi, Masashi Shimoda, Junpei Sanada, Kohei Kaku, Yoshiro Fushimi, Hideaki Kaneto
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Endocrine Disorders
BMC Endocrine Disorders
Background Various adrenal disorders including primary aldosteronism and Cushing’s syndrome lead to the cause of hypertension. Although primary aldosteronism is sometimes complicated with preclinical Cushing’s syndrome, concurrence of overt Cushi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3788f624fe2d0eb71e8ceca1e331e754
https://doaj.org/article/a4a02b5b9dfd47c2845745ab2f457c8a
https://doaj.org/article/a4a02b5b9dfd47c2845745ab2f457c8a
Autor:
Hideaki Kaneto, Masashi Shimoda, Shuhei Nakanishi, Kohei Kaku, Shinji Kamei, Tomohiko Kimura, Atsushi Obata, Yoshiro Fushimi, Junpei Sanada, Fuminori Tatsumi, Tomoatsu Mune
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-5 (2021)
BMC Endocrine Disorders
BMC Endocrine Disorders
Background Multiple endocrine neoplasia type 1 (MEN1) is a syndrome characterized by pituitary neoplasia, primary hyperparathyroidism and pancreatic endocrine tumor. Here we show a case of MEN1 with a germline frameshift mutation in its gene accompan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bda79ae2f395f76272171ea896e299a7
https://doaj.org/article/8c88e3dc93f8443f96a16f8ac303e2ba
https://doaj.org/article/8c88e3dc93f8443f96a16f8ac303e2ba